Export-supported jobs linked to manufacturing account for an estimated 1.2 percent of Hawaii's total private-sector employment. Approximately 5.3 percent of all manufacturing workers in Hawaii depend on exports for their jobs.
Hydergine (generic: ergoloid mesylates), whose chemical name is dihydroergotoxine mesylate, is an FDA-approved drug used to aid in the treatment of older individuals showing signs of neurodegenerative disease. It is thought to have both neuroprotective (protective of the brain cells) and nootropic effects.
Most persons prescribed Hydergine experience little in the way of serious side effects. Some minor effects that were reported include: nasal congestion, nausea and gastric problems (these effects may be reduced if the medication is taken with food), an allergic reaction of the skin, headache, or blurred vision.